日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma

肝功能在治疗开始时的核心作用及其在疾病进展后维持对于接受阿特珠单抗联合贝伐珠单抗治疗的晚期肝细胞癌患者生存期的影响

Ariga, Mizuki; Kuzuya, Teiji; Muto, Hisanori; Tachi, Yoshihiko; Kobayashi, Mariko; Sugiyama, Hijiri; Morisaki, Sayaka; Komura, Gakushi; Nakano, Takuji; Tanaka, Hiroyuki; Nakaoka, Kazunori; Ohno, Eizaburo; Funasaka, Kohei; Nagasaka, Mitsuo; Miyahara, Ryoji; Hirooka, Yoshiki

Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy

基于生物标志物的肝细胞癌治疗应答者筛选和治疗反应早期预测:阿特珠单抗联合贝伐珠单抗治疗期间甲胎蛋白和去羧基凝血酶原的动态变化

Kuzuya, Teiji; Muto, Hisanori; Tachi, Yoshihiko; Kobayashi, Mariko; Sugiyama, Hijiri; Ariga, Mizuki; Morisaki, Sayaka; Komura, Gakushi; Nakano, Takuji; Tanaka, Hiroyuki; Nakaoka, Kazunori; Ohno, Eizaburo; Funasaka, Kohei; Nagasaka, Mitsuo; Miyahara, Ryoji; Hirooka, Yoshiki

Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response

接受阿特珠单抗/贝伐珠单抗联合治疗并达到完全缓解的晚期肝细胞癌患者的特征和预后

Kuzuya, Teiji; Kawabe, Naoto; Muto, Hisanori; Tachi, Yoshihiko; Ukai, Takeshi; Wada, Yuryo; Komura, Gakushi; Nakano, Takuji; Tanaka, Hiroyuki; Nakaoka, Kazunori; Ohno, Eizaburo; Funasaka, Kohei; Nagasaka, Mitsuo; Miyahara, Ryoji; Hirooka, Yoshiki

Successful pancreatectomy after conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for unresectable adenosquamous carcinoma of the pancreas: a case report

一例不可切除的胰腺腺鳞癌患者,在接受吉西他滨和白蛋白紫杉醇化疗后成功行胰腺切除术:病例报告

Nakamura, Kenichi; Nakagawa, Mitsuru; Ariga, Mizuki; Higashiguchi, Takahiko; Chikaishi, Yuko; Matsuo, Kazuhiro; Nishijima, Aki; Endo, Tomoyoshi; Kikuchi, Kenji; Morohara, Koji; Katsuno, Hidetoshi; Tachi, Yoshihiko; Uyama, Ichiro; Suda, Koichi; Morise, Zenichi

Pancreatolithiasis with an anatomic variant of Wirsung duct: a case report

胰管解剖变异合并胰管结石:病例报告

Yamamoto, Satoshi; Inui, Kazuo; Katano, Yoshiaki; Hashimoto, Senju; Miyoshi, Hironao; Kobayashi, Takashi; Tachi, Yoshihiko

Large Inflammatory Myofibroblastic Tumor of the Esophagus: A Case Report and Literature Review

食管巨大炎性肌纤维母细胞瘤:病例报告及文献复习

Yamada, Hyuga; Funasaka, Kohei; Nakagawa, Mitsuru; Hirayama, Yutaka; Horiguchi, Noriyuki; Nagasaka, Mitsuo; Nakagawa, Yoshiyuki; Kuzuya, Teiji; Hashimoto, Senju; Miyahara, Ryoji; Shibata, Tomoyuki; Tachi, Yoshihiko; Tsukamoto, Tetsuya; Hirooka, Yoshiki

Large or multiple pseudocysts can impede or complicate the nonsurgical treatment of pancreatolithiasis

较大的或多个假性囊肿会阻碍或使胰腺结石的非手术治疗复杂化。

Yamamoto, Satoshi; Inui, Kazuo; Katano, Yoshiaki; Miyoshi, Hironao; Kobayashi, Takashi; Tachi, Yoshihiko

Nonsurgical treatment for asymptomatic pancreatolithiasis is meaning: A case report

无症状胰腺结石的非手术治疗意义:病例报告

Yamamoto, Satoshi; Inui, Kazuo; Katano, Yoshiaki; Miyoshi, Hironao; Kobayashi, Takashi; Tachi, Yoshihiko; Hattori, Masashi

Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.

12 周索非布韦/维帕他韦治疗失代偿期肝硬化基因 1 型和 2 型患者的真实世界临床应用:一项前瞻性多中心研究

Atsukawa Masanori, Tsubota Akihito, Kondo Chisa, Toyoda Hidenori, Nakamuta Makoto, Takaguchi Koichi, Watanabe Tsunamasa, Hiraoka Atsushi, Uojima Haruki, Ishikawa Toru, Iwasa Motoh, Tada Toshifumi, Nozaki Akito, Chuma Makoto, Fukunishi Shinya, Asai Akira, Asano Toru, Ogawa Chikara, Abe Hiroshi, Hotta Naoki, Shima Toshihide, Iio Etsuko, Mikami Shigeru, Tachi Yoshihiko, Fujioka Shinichi, Okubo Hironao, Shimada Noritomo, Tani Joji, Hidaka Isao, Moriya Akio, Tsuji Kunihiko, Akahane Takehiro, Yamashita Naoki, Okubo Tomomi, Arai Taeang, Morita Kiyoshi, Kawata Kazuhito, Tanaka Yasuhito, Okanoue Takeshi, Maeda Shin, Kumada Takashi, Iwakiri Katsuhiko

Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

日本高发老年患者、肝硬化和肝细胞癌地区无干扰素抗丙型肝炎病毒疗法的趋势和疗效:一项纳入10688例患者的真实世界、全国性、多中心研究

Toyoda, Hidenori; Atsukawa, Masanori; Uojima, Haruki; Nozaki, Akito; Tamai, Hideyuki; Takaguchi, Koichi; Fujioka, Shinichi; Nakamuta, Makoto; Tada, Toshifumi; Yasuda, Satoshi; Chuma, Makoto; Senoh, Tomonori; Tsutsui, Akemi; Yamashita, Naoki; Hiraoka, Atsushi; Michitaka, Kojiro; Shima, Toshihide; Akahane, Takehiro; Itobayashi, Ei; Watanabe, Tsunamasa; Ikeda, Hiroki; Iio, Etsuko; Fukunishi, Shinya; Asano, Toru; Tachi, Yoshihiko; Ikegami, Tadashi; Tsuji, Kunihiko; Abe, Hiroshi; Kato, Keizo; Mikami, Shigeru; Okubo, Hironao; Shimada, Noritomo; Ishikawa, Toru; Matsumoto, Yoshihiro; Itokawa, Norio; Arai, Taeang; Tsubota, Akihito; Iwakiri, Katsuhiko; Tanaka, Yasuhito; Kumada, Takashi